Researchers in Sweden reporting in Neurology found that adults who consumed 50 grams or more of high-fat cheese daily had a statistically lower risk of developing dementia over roughly 25 years of follow-up. The analysis used data from the Malmö Diet and Cancer cohort, tracking 27,670 participants between baseline dietary assessment and dementia diagnoses; 3,208 developed dementia during follow-up. After adjusting for age, sex, education and overall diet, daily intake of high-fat cheese (defined by the study as cheeses >20% fat) was associated with a 13% lower all-cause dementia risk compared with very low intake. The authors and independent experts caution the result shows an association, not proof of causation, and note several important limitations of the observational design.
Key Takeaways
- The cohort comprised 27,670 Swedish adults followed for about 25 years; 3,208 participants (11.6%) developed dementia.
- Eating ≥50 g/day of high-fat cheese correlated with a 13% lower adjusted risk of all-cause dementia compared with <15 g/day.
- High-fat cheeses in the study included varieties with >20% fat such as brie, gouda, cheddar, parmesan, gruyere and mozzarella.
- No protective association was observed for low-fat cheese, any kind of milk, or fermented milks (yogurt, kefir) in this analysis.
- Butter showed mixed signals; very high butter intake was linked to a possible increased Alzheimer’s risk in some comparisons.
- Dietary intake was recorded at a single baseline time point using a 7-day diary, food-frequency questionnaire and interview, raising potential for misclassification over 25 years.
- The paper emphasizes association only; underlying biological mechanisms remain unresolved and require further study.
Background
Dietary guidance has long debated the risks and benefits of high-fat versus low-fat foods, with dairy frequently scrutinized in cardiovascular and metabolic research. For decades public-health messaging often advised limiting high-fat dairy, even as dietary science evolved to recognize food matrix and nutrient context as important modifiers of health effects. Dementia — a group of conditions marked by progressive cognitive decline, led by Alzheimer’s disease — affects millions worldwide and has limited treatment options, making primary prevention a major research focus. Large observational cohorts and diet-pattern studies, such as research on the Mediterranean and MIND diets, have produced mixed results on dairy and cognitive outcomes, so individual food-level analyses remain relevant to refine guidance.
The Malmö Diet and Cancer Study (MDCS) is a long-running Swedish cohort designed to relate habitual diet and lifestyle to chronic disease outcomes. Past MDCS analyses have contributed to understanding diet–disease links across cardiovascular, cancer and metabolic endpoints. International studies from Finland, the UK and Japan have reported inconsistent associations between cheese or dairy and dementia, with differences in intake levels, dairy processing and population diets complicating comparisons. The new analysis led by Yufeng Du of Lund University aimed specifically to clarify whether high-fat dairy or particular cheese types were associated with dementia risk over extended follow-up.
Main Event
The research team analyzed 27,670 participants from the MDCS who provided detailed baseline dietary data using a 7-day food diary, a food-frequency questionnaire and a structured interview about preparation and habits. Investigators categorized dairy intake and isolated high-fat cheese (cheeses >20% fat content) and compared dementia outcomes across intake groups. Over the ~25-year observation window, 3,208 participants were recorded with a dementia diagnosis; incidence varied across cheese-consumption strata. Roughly 10% of participants who consumed ≥50 g/day of high-fat cheese developed dementia, compared with about 13% among those who ate <15 g/day.
After statistical adjustment for age, sex, education and total diet quality, the highest high-fat cheese consumers had a 13% lower all-cause dementia risk than the lowest consumers. The association remained detectable in several sensitivity checks reported by the authors but was attenuated in some subgroup analyses. The study did not find similar associations for low-fat cheeses, milk, or fermented milk products such as yogurt and kefir; butter produced mixed results and in some high-intake comparisons suggested a possible increased Alzheimer’s risk.
Authors and peer reviewers highlighted methodological constraints: dietary exposure was assessed only at baseline, so lifetime changes in diet were not captured; observational confounding (by socioeconomic status, lifestyle or health conditions) cannot be fully excluded; and the biological pathway that could explain a protective association with high-fat cheese is not identified in the paper. The study was published in Neurology and presented as evidence of a statistically detectable association rather than a proven protective effect.
Analysis & Implications
Biologically, several hypotheses could explain an association between high-fat cheese and lower dementia risk, but none are proven: cheese contains fat-soluble nutrients, certain B vitamins and minerals, and fermentation-derived compounds that might influence brain health or vascular risk factors. The cheese food matrix — how nutrients interact within a whole food — can alter digestion and metabolic effects compared with isolated fats, which complicates simplistic high-fat/low-fat conclusions. However, the study did not measure biomarkers or direct mechanistic endpoints (for example, inflammatory markers, lipid fractions, or neuroimaging), so mechanistic interpretation remains speculative.
From a public-health perspective, the finding suggests that blanket advice to avoid all high-fat dairy may be oversimplified, but it does not justify recommending large amounts of high-fat cheese for dementia prevention. Cheese is calorie-dense and can contribute to saturated fat and sodium intake, which are relevant for cardiovascular health — itself a determinant of vascular cognitive impairment. Any dietary recommendations would need to balance cognitive, cardiovascular and metabolic outcomes and consider total dietary patterns rather than single foods.
For researchers, the study highlights priorities: replication in other cohorts with repeated dietary measures, use of objective biomarkers of dairy intake, mediation analysis by cardiometabolic and inflammatory pathways, and ultimately randomized or mechanistic trials where feasible. Policymakers should view the result as hypothesis-generating; current dementia-prevention guidelines focus on overall healthy lifestyle patterns, not isolated food prescriptions. Given the projected rise in dementia cases globally — from an estimated 57 million in 2021 to potentially over 150 million by mid-century — clarifying modifiable dietary factors remains urgent.
Comparison & Data
| Measure | Value |
|---|---|
| Cohort size | 27,670 participants |
| Follow-up | ~25 years |
| Total dementia cases | 3,208 (11.6%) |
| Incidence, ≥50 g/day high-fat cheese | ~10% |
| Incidence, <15 g/day high-fat cheese | ~13% |
| Adjusted relative difference | 13% lower all-cause dementia risk for high vs very low intake |
The table summarizes the primary numerical findings reported. Percentages are cohort incidences over the approximately 25-year follow-up; the relative 13% reduction refers to the adjusted hazard comparison between the highest and lowest high-fat cheese intake groups. Cross-study comparisons are limited by differing intake definitions, follow-up lengths and covariate adjustments.
Reactions & Quotes
Lead and co-authors framed the result as a challenge to simplistic fat-based guidance and as a call for further research into specific dairy products and cognitive outcomes.
“Some high-fat dairy products may actually lower the risk of dementia, challenging some long-held assumptions about fat and brain health.”
Emily Sonestedt, Nutrition Epidemiologist, Lund University (co-author)
Independent experts praised the cohort size and follow-up length but emphasized the limits of a single baseline dietary measure and the observational design.
“Diet and other lifestyle factors likely changed in those 25 years; that is a major limitation for attributing long-term outcomes to one baseline report.”
Tara Spires-Jones, Division Lead, UK Dementia Research Institute (independent expert)
Unconfirmed
- Whether the observed link reflects a causal protective effect of high-fat cheese rather than confounding by other healthy behaviors remains unproven.
- The specific biological mechanism(s) that could mediate a protective association (nutrients, fermentation products, microbiome effects) are hypothetical and not demonstrated here.
- Stability of individual participants’ cheese consumption over the entire 25-year follow-up is unknown because diet was measured only at baseline.
Bottom Line
This large, long-term Swedish cohort study reports a statistically detectable association between daily consumption of ≥50 g of high-fat cheese and a 13% lower adjusted all-cause dementia risk versus very low intake, but it does not establish causation. The finding adds nuance to the debate over high-fat dairy but should not be interpreted as a recommendation to substantially increase cheese intake without considering overall calorie, saturated fat and sodium balance.
Clinicians and individuals should continue to prioritize established dementia risk-reduction strategies — regular physical activity, cardiovascular risk control, cognitive engagement and balanced diets — while researchers pursue replication, biomarker-based studies and mechanistic work to determine whether and how specific dairy products may influence brain health.